Cornercap Investment Counsel’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,791
| Closed | -$67.2K | – | 479 |
|
|
2024
Q3 | $67.2K | Sell |
11,791
-15,345
| -57% | -$87.5K | 0.02% | 499 |
|
|
2024
Q2 | $125K | Buy |
+27,136
| New | +$125K | 0.02% | 567 |
|
|
2024
Q1 | – | Sell |
-46,286
| Closed | -$262K | – | 617 |
|
|
2023
Q4 | $262K | Sell |
46,286
-1,170
| -2% | -$6.61K | 0.04% | 498 |
|
|
2023
Q3 | $88.3K | Sell |
47,456
-591
| -1% | -$1.1K | 0.02% | 537 |
|
|
2023
Q2 | $132K | Hold |
48,047
| – | – | 0.02% | 540 |
|
|
2023
Q1 | $151K | Buy |
48,047
+21,756
| +83% | +$68.3K | 0.03% | 525 |
|
|
2022
Q4 | $155K | Buy |
26,291
+4,690
| +22% | +$27.7K | 0.03% | 524 |
|
|
2022
Q3 | $189K | Buy |
21,601
+1,203
| +6% | +$10.5K | 0.04% | 502 |
|
|
2022
Q2 | $154K | Buy |
+20,398
| New | +$154K | 0.03% | 502 |
|